Company: PHIL
Filing Date: 2025-02-19
Form Type: 10-Q
Source: 0001493152-25-007556
Chunk: 4

Company: PHI GROUP INC
Filing Date: 2025-02-19
Form: 10-Q
Item: Part I, Item 1
Chunk 4
---
 cash equivalents, beginning of period 
     303  
     19,765 
  
    Cash and cash equivalents, end of period 
    $310  
    $29,442 

The
accompanying notes form an integral part of these audited consolidated financial statements

F-3

PHI
GROUP, INC. AND SUBSIDIARIES

STATEMENT
OF STOCKHOLDERS’ EQUITY (DEFICIT)

FOR
THE QUARTER ENDED DECEMBER 31, 2024 (UN-AUDITED)

    Additional  
    Preferred  
    Stock  
    Additional  

    Common  
    Common  
    Other  
       
    Total 

    Common
    Stock  
    Paid-in  
    Stock  
    Par  
    Paid-in  
    Treasury  
    Stock  
    Stock to be  
    Stock to be  
    Comprehensive  
    Accumulated  
    Shareholder 

    Shares  
    Par Value  
    Capital  
    Shares  
    Value  
    Capital  
    Shares  
    Amount  
    cancelled  
    issued  
    Gain (loss)  
    Deficit  
    Deficit 
  
    Balance at fiscal year ended June 30, 2023 
     39,414,493,275  
     39,414,493  
     32,773,102  
     600,000  
     600  
     1,840  
     (484,767) 
     (44,170) 
            (35,000) 
              22,500  
    $(3,035,495) 
    $(77,319,372) 
    $(8,222,002)
  
    Common shares issued for conversion of notes by Brin Financial Corporation
    during 9/30/23 quarter 
     171,561,860  
     171,562  
     (68,625) 

     102,937 
  
    Common Shares issued for exercise of warrants by Mast Hill Fund LP during
    9/30/23 quarter 
     2,931,619,052  
     2,931,619  
     (1,175,299) 

     1,756,320